IBANDRONATE Sandoz sol inj 3 mg/3ml ser pré 3 ml
7680605320012
CH-60532
M05BA06
07.99.0.
Active substances:
1 / 2
Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 6053201
- CPT
- -
- Packaging group
- 1
- Unit
- Spritze(n)
- Composition
- acidum ibandronicum 3 mg ut natrii ibandronas monohydricus, acidum citricum monohydricum, natrii chloridum, natrii hydroxidum, acidum hydrochloridum concentratum, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 12 mg.
Articles (1)
Ibandronat Sandoz i.v., Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
acidum ibandronicum
|
3.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii ibandronas monohydricus
|
- | Substance | WIZUS |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum hydrochloridum concentratum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
12.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 64.35
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2011
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 60532
- Drug name
- Ibandronat Sandoz i.v., Injektionslösung
- Galenic form
- LSPA
- ATC Code
- M05BA06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/07/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IBANDRONATE Sandoz sol inj 3 mg/3ml ser pré 3 ml
- Description (DE)
- IBANDRONAT Sandoz Inj Lös 3 mg/3ml Fertspr 3 ml
- Market launch
- 29/07/2010
- Narcotic (BTM)
- No
Original drug
Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680574240014
CHF 210.75